Genetic counseling is recommended for individuals with BRCA1/2 mutations because of the well-documented advantages of surveillance, chemoprevention and risk-reducing surgeries in managing breast and ovarian cancer [34]. This evidence concerns the gene BRCA1 and ovarian cancer.